Reovirus for the treatment of cellular proliferative disorders

Details Reovirus for the treatment of cellular proliferative disorders Reovirus for the treatment of cellular proliferative disorders

A - Human Necessities

61

K

A61K 35/76 (2006.01) A61K 31/664 (2006.01) A61P 35/00 (2006.01) C12N 7/00 (2006.01)

Patent

CA 2615684

Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that it ultimately directly contacts ras-mediated proliferating cells. Proliferative disorders include but are not limited to neoplasms. Human reovirus, non-human mammalian reovirus, and/or avian reovirus can be used. If the reovirus is human reovirus, serotype 1(e.g., strain Lang), serotype 2 (e.g., strain Jones), serotype 3 (e.g., strain Dearing or strain Abney), as well as other serotypes or strains of reovirus can be used. Combinations of more than one type and/or strain of reovirus can be used, as can reovirus from different species of animal. Either solid neoplasms or hematopoietic neoplasms can be treated.

Affiliated with

Also associated with

Rating

Reovirus for the treatment of cellular proliferative disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reovirus for the treatment of cellular proliferative disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reovirus for the treatment of cellular proliferative disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1480637